Medifirst Solutions, Inc. Announces Shareholder Update
Wednesday, 02 December 2015 09:30 AM
FREEHOLD, NJ / ACCESSWIRE / December 2, 2015 / MEDIFIRST SOLUTIONS, INC. (OTCQB: MFST) would like to update existing and new shareholders on both recent and ongoing company events. Commented CEO Bruce J Schoengood, "During this past year management has made a strategic decision to pare down and consolidate the focus and divisions of the company to its proprietary hand-held mobile laser devices which it feels represents the most value and perspective growth for both the company and its shareholders. This restructure will create a clear understanding and path for business development and strategy for sales and growth over the next 12 months." Medical Lasers Manufacturer, a wholly-owned subsidiary, will house and operate the laser division, related products and treatment programs. Driven by the huge demand for non-invasive skin and pain treatments, the global market for medical and therapeutic lasers have been estimated to grow as high as to $4 billion in 2015. Recent company developments are as follows:
510(k) FDA Submission
Medifirst previously announced its 510(k) submission for its Green and Infrared laser devices was accepted by the Center for Devices and Radiological Health (CDRH) of the Food and Drug Administration (FDA) and was assigned a unique document control number. Our consulting company has been in contact with the FDA and we expect to have several updates in the upcoming days and weeks. Continued CEO Schoengood, "This is a very exciting time for Medifirst. The laser devices are very unique and offer an easy-to-use, mobile, affordable and effective product for many different healthcare professionals. The treatment program can serve to enhance their current treatment protocols as well as produce additional revenue streams. While under FDA review, Medifirst will continue to fine-tune and develop its national sales, marketing and social media strategy so it can hit the ground running in anticipation of FDA approval."
International Sales
The laser systems have all certifications needed and required for international sales and Medifirst continues set up affiliations for international distribution.
About the Lasers
Medical Lasers Manufacturer, Inc., a Medifirst subsidiary, will specialize in producing high quality diode-pumped solid-state lasers. The laser division including products and treatment programs will be operated out of MLM. Our focus is to help patients with specific cosmetic skin conditions, as well as relief of muscle and joint pain, muscle spasm and inflammation. MLM's team consists of a group of engineers with decades of experience in laser research and manufacturing that have been providing customized laser products to a wide variety of universities and labs. MLM plans to develop new laser products to meet the universal medical needs including new applications which will all adhere to FDA requirements and guidelines. MLM has met all the ISO International Standards to ensure that products and services are safe, reliable and of good quality. All Lasers we bring to market will have EMC, IEC and CE certifications.
The Time Machine Program
The company has developed treatment protocols that will be marketed under The Time Machine Program. This program will include several skin products that will be used in conjunction with the specific laser protocols.
Social Media
We urge our shareholders to stay up-to-date with our social media and visit Medifirst Solutions on Facebook, Twitter (Medifirst Solutions @Medi-First) and Instagram (@The TimeMachineProgram). Visit www.medifirstsolutions.com for links to all social media websites.
About Medifirst Solutions, Inc.
Medifirst Solutions, Inc. is a Nevada corporation that is headquartered in New Jersey. The company seeks innovative medical and healthcare products and technologies which are targeted to both medical and healthcare professionals as well as everyday consumers. Medifirst Solutions is developing and establishing both consumer and professional medical clientele that can serve as a pipeline that will allow for distribution of future new products and services. For more details visit www.medifirstsolutions.com for more information.
FOR IMMEDIATE RELEASE
Contact: Investor Relations
Phone: (732) 786-8044
Email: [email protected]
Website: www.medifirstsolutions.com
Forward-Looking Statements: The statements in this press release that relate to the company's expectations with regard to the future impact on the company's results from new products in development are forward-looking statements, and may involve risks and uncertainties, some of which are beyond our control. Such risks and uncertainties are described in greater detail in our filings with the U.S. Securities and Exchange Commission. Since the information in this press release may contain statements that involve risk and uncertainties and are subject to change at any time, the company's actual results may differ materially from expected results. We make no commitment to disclose any subsequent revisions to forward-looking statements.
SOURCE: Medifirst Solutions, Inc.
